NIAID Banner Logo Image

HBV Citations List: June 2023

Literature Citations

1. Amentoflavone Inhibits Hepatitis B Virus Infection via the Suppression of Pres1 Binding to Host Cells. Aoki-Utsubo, C., P. Indrasetiawan, K. Fukano, M. Muramatsu, N. Artanti, M. Hanafi, H. Hotta, and M. Kameoka. Microbiology and Immunology, 2023. 67(6): p. 281-292. PMID[36929353].
[PubMed]. HBV_06_2023.

2. A Prodrug of the Capsid Assembly Modulator Improved Druggability and Lowing HBsAg and HBeAg for the Treatment of Chronic Hepatitis B. Chen, W.H., Y. Gong, G.Z. Long, X.R. Wang, Y.R. Yang, J. Liu, H. Li, X.K. Tong, Q.L. Zhao, L. Yang, J.P. Zuo, and Y.H. Hu. European Journal of Medicinal Chemistry, 2023. 257: 115485. PMID[37229833].
[PubMed]. HBV_06_2023.

3. Effect of Solvation on the Molecular Structure, Vibrational Assignment, Nature of Bonding, and the Antiviral Drug-like Potential of Troxerutin against HBV Proteins. Cheng, C.R., U.O. Edet, I. Benjamin, C.U. Okoro, W. Emori, E.N. Mbim, O.C. Godfrey, F.O. Nwaokorie, J.O. Mbah, R.U. Ukpanukpong, A.L.E. Manicum, and H. Louis. Journal of the Indian Chemical Society, 2023. 100(6): 100994. ISI[001002774000001].
[WOS]. HBV_06_2023.

4. Discovery of 5-Alkyl-2-pyrazol-oxazolidin-4-one Derivatives as Novel Hepatitis B Virus Capsid Assembly Modulators. Guan, M., Y. Wang, Y. Wang, N. Chen, S. Shi, and R. Sheng. Archiv der Pharmazie, 2023. 356(6): e2200592. PMID[37021586].
[PubMed]. HBV_06_2023.

5. The Specific Core Fucose-Binding Lectin Pholiota squarrosa Lectin (PhoSL) Inhibits Hepatitis B Virus Infection in Vitro. Ouchida, T., H. Maeda, Y. Akamatsu, M. Maeda, S. Takamatsu, J. Kondo, R. Misaki, Y. Kamada, M. Ueda, K. Ueda, and E. Miyoshi. Scientific Reports, 2023. 13(1). PMID[37061516]. PMCID[PMC10105536].
[PubMed]. HBV_06_2023.

6. Notoginsenoside R1 Inhibits Hepatitis B Virus Replication by Modulating SIRT1 Activity. Zhang, W.J., J.J. Cui, L.C. Li, L.J. Chai, Q.L. Hou, and H.Q. Yu. Acta Virologica, 2023. 67(1): p. 51-58. PMID[36950885].
[PubMed]. HBV_06_2023.

Patent Citations

7. Ginsenosides for Treatment of Chronic Hepatitis B Virus Infections. Miller, A.D., D. Ruzek, G.S. Duraisamy, V. Adam, and Z. Heger. Patent. 2023. WO2022-CZ50128 2023104227: 27pp.
[Patent]. HBV_06_2023.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2023